Opko Health Stock Analysis

OPK Stock  USD 1.37  0.02  1.48%   
Opko Health is undervalued with Real Value of 2.02 and Target Price of 3.99. The main objective of Opko Health stock analysis is to determine its intrinsic value, which is an estimate of what Opko Health is worth, separate from its market price. There are two main types of Opko Health's stock analysis: fundamental analysis and technical analysis.
The Opko Health stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA.
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Opko Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.
For more information on how to buy Opko Stock please use our How to buy in Opko Stock guide.

Opko Stock Analysis Notes

About 47.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 0.82. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Opko Health recorded a loss per share of 0.06. The entity had not issued any dividends in recent years. OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company was founded in 1991 and is headquartered in Miami, Florida. Opko Health operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 5767 people. To find out more about Opko Health contact Phillip Frost at 305 575 4100 or learn more at https://www.opko.com.

Opko Health Investment Alerts

Opko Health generated a negative expected return over the last 90 days
Opko Health may become a speculative penny stock
The company reported the last year's revenue of 713.14 M. Reported Net Loss for the year was (53.22 M) with profit before taxes, overhead, and interest of 104.94 M.
Opko Health has about 210.46 M in cash with (183.49 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.27.
Roughly 47.0% of the company outstanding shares are owned by corporate insiders
Latest headline from thelincolnianonline.com: OPKO Health Upgraded at LADENBURG THALMSH SH

Opko Health Upcoming and Recent Events

22nd of February 2024
Upcoming Quarterly Report
View
1st of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
22nd of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Opko Largest EPS Surprises

Earnings surprises can significantly impact Opko Health's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2016-02-29
2015-12-310.00170.00290.001270 
2023-11-06
2023-09-30-0.1-0.11-0.0110 
2021-02-18
2020-12-310.040.050.0125 
View All Earnings Estimates

Opko Stock Institutional Investors

Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
Bank Of America Corp2025-03-31
4.2 M
Morgan Stanley - Brokerage Accounts2025-03-31
4.1 M
Goldman Sachs Group Inc2025-03-31
M
Lazard Asset Management Llc2025-03-31
3.6 M
Northern Trust Corp2025-03-31
3.5 M
Charles Schwab Investment Management Inc2025-03-31
2.7 M
Jpmorgan Chase & Co2025-03-31
2.5 M
Ubs Group Ag2025-03-31
2.4 M
Dimensional Fund Advisors, Inc.2025-03-31
2.2 M
Rubric Capital Management Lp2025-03-31
48.7 M
Vanguard Group Inc2025-03-31
29.5 M
Note, although Opko Health's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Opko Market Capitalization

The company currently falls under 'Mid-Cap' category with a total capitalization of 1.07 B.

Opko Profitablity

The company has Net Profit Margin of (0.06) %, which means that it does not effectively control expenditures or properly executes on its pricing strategies. This is way below average. In the same way, it shows Net Operating Margin of (0.45) %, which entails that for every $100 of revenue, it lost $0.45.
Last ReportedProjected for Next Year
Return On Tangible Assets(0.06)(0.06)
Return On Capital Employed(0.08)(0.08)
Return On Assets(0.02)(0.03)
Return On Equity(0.04)(0.04)

Management Efficiency

Opko Health has Return on Asset of (0.082) % which means that on every $100 spent on assets, it lost $0.082. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (0.0304) %, meaning that it generated no profit with money invested by stockholders. Opko Health's management efficiency ratios could be used to measure how well Opko Health manages its routine affairs as well as how well it operates its assets and liabilities. The value of Return On Tangible Assets is estimated to slide to -0.07. The value of Return On Capital Employed is expected to slide to -0.08. At this time, Opko Health's Liabilities And Stockholders Equity is quite stable compared to the past year. Non Current Liabilities Total is expected to rise to about 673.8 M this year, although the value of Total Current Liabilities will most likely fall to about 107.5 M.
Last ReportedProjected for Next Year
Book Value Per Share 1.97  1.19 
Tangible Book Value Per Share 0.04  0.03 
Enterprise Value Over EBITDA 8.08  8.48 
Price Book Value Ratio 0.75  0.71 
Enterprise Value Multiple 8.08  8.48 
Price Fair Value 0.75  0.71 
Enterprise Value1.1 B1.4 B
Effective leadership at Opko Health drives its competitive edge in the market. Our analysis focuses on how this translates to financial performance and stock value.
Operating Margin
(0.45)
Profit Margin
(0.06)
Beta
1.367
Return On Assets
(0.08)
Return On Equity
(0.03)

Technical Drivers

As of the 21st of July, Opko Health holds the Variance of 4.55, risk adjusted performance of (0.02), and Coefficient Of Variation of (3,937). Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Opko Health, as well as the relationship between them.

Opko Health Price Movement Analysis

The output start index for this execution was twenty-nine with a total number of output elements of thirty-two. The Simple Moving Average indicator is calculated by adding the closing price of Opko Health for a given number of time periods and then dividing this total by the number of time periods. It is used to smooth out Opko Health short-term fluctuations and highlight longer-term trends or cycles.

Opko Health Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Opko Health insiders, such as employees or executives, is commonly permitted as long as it does not rely on Opko Health's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Opko Health insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Phillip Frost over three weeks ago
Acquisition by Phillip Frost of 78674 shares of Opko Health at 1.27 subject to Rule 16b-3
 
Zerhouni Elias A. over a month ago
Acquisition by Zerhouni Elias A. of 500000 shares of Opko Health at 1.31 subject to Rule 16b-3
 
Nabel Gary J. over a month ago
Acquisition by Nabel Gary J. of 437500 shares of Opko Health at 1.31 subject to Rule 16b-3
 
Phillip Frost over two months ago
Acquisition by Phillip Frost of 47537 shares of Opko Health at 1.4738 subject to Rule 16b-3
 
Yu Alice Lin-tsing over two months ago
Acquisition by Yu Alice Lin-tsing of 30000 shares of Opko Health at 1.47 subject to Rule 16b-3
 
Phillip Frost over three months ago
Acquisition by Phillip Frost of 125000 shares of Opko Health at 1.3577 subject to Rule 16b-3
 
Phillip Frost over three months ago
Acquisition by Phillip Frost of 125000 shares of Opko Health at 1.4772 subject to Rule 16b-3
 
Phillip Frost over three months ago
Acquisition by Phillip Frost of 100000 shares of Opko Health at 1.6485 subject to Rule 16b-3
 
Phillip Frost over three months ago
Acquisition by Phillip Frost of 1500000 shares of Opko Health at 0.8964 subject to Rule 16b-3
 
Phillip Frost over three months ago
Acquisition by Phillip Frost of 150000 shares of Opko Health at 1.6959 subject to Rule 16b-3
 
Phillip Frost over three months ago
Acquisition by Phillip Frost of 10101 shares of Opko Health at 1.265 subject to Rule 16b-3
 
Phillip Frost over three months ago
Acquisition by Phillip Frost of tradable shares of Opko Health at 1.15 subject to Rule 16b-3

Opko Health Outstanding Bonds

Opko Health issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Opko Health uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Opko bonds can be classified according to their maturity, which is the date when Opko Health has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Opko Health Predictive Daily Indicators

Opko Health intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Opko Health stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Opko Health Forecast Models

Opko Health's time-series forecasting models are one of many Opko Health's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Opko Health's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Opko Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Opko Health prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Opko shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Opko Health. By using and applying Opko Stock analysis, traders can create a robust methodology for identifying Opko entry and exit points for their positions.
Last ReportedProjected for Next Year
Pretax Profit Margin(0.01)(0.02)
Operating Profit Margin(0.21)(0.22)
Net Loss(0.07)(0.08)
Gross Profit Margin 0.44  0.39 

Current Opko Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Opko analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Opko analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
3.99Strong Buy7Odds
Opko Health current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Opko analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Opko stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Opko Health, talking to its executives and customers, or listening to Opko conference calls.
Opko Analyst Advice Details

Opko Stock Analysis Indicators

Opko Health stock analysis indicators help investors evaluate how Opko Health stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Opko Health shares will generate the highest return on investment. By understating and applying Opko Health stock analysis, traders can identify Opko Health position entry and exit signals to maximize returns.
Begin Period Cash Flow95.9 M
Long Term Debt422.2 M
Common Stock Shares Outstanding694 M
Total Stockholder Equity1.4 B
Total Cashflows From Investing Activities352.2 M
Tax Provision42.8 M
Quarterly Earnings Growth Y O Y0.191
Property Plant And Equipment Net124.1 M
Cash And Short Term Investments431.9 M
Cash431.9 M
Accounts Payable47.1 M
Net Debt72.5 M
50 Day M A1.3248
Total Current Liabilities193.1 M
Other Operating Expenses865.2 M
Non Current Assets Total1.5 B
Forward Price Earnings64.5161
Non Currrent Assets Other18.5 M
Stock Based Compensation11 M
When determining whether Opko Health is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Opko Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Opko Health Stock. Highlighted below are key reports to facilitate an investment decision about Opko Health Stock:
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Opko Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.
For more information on how to buy Opko Stock please use our How to buy in Opko Stock guide.
You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Opko Health. If investors know Opko will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Opko Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.191
Earnings Share
(0.06)
Revenue Per Share
1.006
Quarterly Revenue Growth
(0.14)
Return On Assets
(0.08)
The market value of Opko Health is measured differently than its book value, which is the value of Opko that is recorded on the company's balance sheet. Investors also form their own opinion of Opko Health's value that differs from its market value or its book value, called intrinsic value, which is Opko Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Opko Health's market value can be influenced by many factors that don't directly affect Opko Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Opko Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Opko Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Opko Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.